Management of toxicities from antibody – drug conjugates in breast cancer - Top-Institutions - MDSpire

Management of toxicities from antibody – drug conjugates in breast cancer

  • By

  • Ajay Gogia

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    International Breast Cancer Centre
    International Breast Cancer Centre

    Barcelona, Spain

    Key Differentiators

    • Oncology

  • #3

    IOB Madrid
    IOB Madrid

    Madrid, Spain

    Key Differentiators

    • Oncology

  • #4

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, MA

    Key Differentiators

    • Oncology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

Original Source(s)

Management of toxicities from antibody – drug conjugates in breast cancer

  • by Ajay Gogia

  • May 29, 2026

Related Content

Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series